Picture of Amicus Therapeutics logo

FOLD — Amicus Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Brief: Amicus Therapeutics Q2 Revenue USD 126.7 Million Vs. IBES Estimate USD 121.2 Million

Aug 08 (Reuters) - Amicus Therapeutics Q2 EPS USD -0.05.
* Q2 operating expenses USD 100.4 million
* Q2 adjusted operating expenses USD 82.1 million
* Q2 net income USD -15.7 million

Recent news on Amicus Therapeutics

See all news